FDA Approves BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited secured FDA approval for its generic Brimonidine Tartrate and Timolol Maleate ophthalmic solution, allowing the company to expand its product portfolio and capture additional market share within the growing ophthalmic segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day